BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

359 related articles for article (PubMed ID: 24102244)

  • 1. Biochemical diagnosis of phaeochromocytoma using plasma-free normetanephrine, metanephrine and methoxytyramine: importance of supine sampling under fasting conditions.
    Därr R; Pamporaki C; Peitzsch M; Miehle K; Prejbisz A; Peczkowska M; Weismann D; Beuschlein F; Sinnott R; Bornstein SR; Neumann HP; Januszewicz A; Lenders J; Eisenhofer G
    Clin Endocrinol (Oxf); 2014 Apr; 80(4):478-86. PubMed ID: 24102244
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reference intervals for plasma free metanephrines with an age adjustment for normetanephrine for optimized laboratory testing of phaeochromocytoma.
    Eisenhofer G; Lattke P; Herberg M; Siegert G; Qin N; Därr R; Hoyer J; Villringer A; Prejbisz A; Januszewicz A; Remaley A; Martucci V; Pacak K; Ross HA; Sweep FC; Lenders JW
    Ann Clin Biochem; 2013 Jan; 50(Pt 1):62-9. PubMed ID: 23065528
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Levodopa therapy in Parkinson's disease: influence on liquid chromatographic tandem mass spectrometric-based measurements of plasma and urinary normetanephrine, metanephrine and methoxytyramine.
    Eisenhofer G; Brown S; Peitzsch M; Pelzel D; Lattke P; Glöckner S; Stell A; Prejbisz A; Fassnacht M; Beuschlein F; Januszewicz A; Siegert G; Reichmann H
    Ann Clin Biochem; 2014 Jan; 51(Pt 1):38-46. PubMed ID: 23873873
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Screening for phaeochromocytoma and paraganglioma: impact of using supine reference intervals for plasma metanephrines with samples collected from fasted/seated patients.
    Casey R; Griffin TP; Wall D; Dennedy MC; Bell M; O'Shea PM
    Ann Clin Biochem; 2017 Jan; 54(1):170-173. PubMed ID: 27166307
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Plasma methoxytyramine: clinical utility with metanephrines for diagnosis of pheochromocytoma and paraganglioma.
    Rao D; Peitzsch M; Prejbisz A; Hanus K; Fassnacht M; Beuschlein F; Brugger C; Fliedner S; Langton K; Pamporaki C; Gudziol V; Stell A; Januszewicz A; Timmers HJLM; Lenders JWM; Eisenhofer G
    Eur J Endocrinol; 2017 Aug; 177(2):103-113. PubMed ID: 28476870
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Supine or Sitting? Economic and other considerations for use of plasma metanephrines for diagnosis of phaeochromocytoma.
    Eisenhofer G; Därr R; Pamporaki C; Peitzsch M; Bornstein S; Lenders JW
    Clin Endocrinol (Oxf); 2015 Mar; 82(3):463-4. PubMed ID: 25186957
    [No Abstract]   [Full Text] [Related]  

  • 7. Age-specific pediatric reference intervals for plasma free normetanephrine, metanephrine, 3-methoxytyramine and 3-O-methyldopa: Particular importance for early infancy.
    Peitzsch M; Mangelis A; Eisenhofer G; Huebner A
    Clin Chim Acta; 2019 Jul; 494():100-105. PubMed ID: 30904545
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Supine or sitting plasma metanephrine screening? A unifying solution for patients and doctors.
    Chortis V; Bancos I; Crowley RK; Arlt W
    Clin Endocrinol (Oxf); 2015 May; 82(5):776-7. PubMed ID: 25376196
    [No Abstract]   [Full Text] [Related]  

  • 9. Supine or sitting? Economic considerations regarding patient position during plasma metanephrine analysis for the exclusion of chromaffin tumours.
    Chortis V; Bancos I; Crowley RK; Arlt W
    Clin Endocrinol (Oxf); 2015 Mar; 82(3):462-3. PubMed ID: 25130622
    [No Abstract]   [Full Text] [Related]  

  • 10. Influence of various confounding variables and storage conditions on metanephrine and normetanephrine levels in plasma.
    Deutschbein T; Unger N; Jaeger A; Broecker-Preuss M; Mann K; Petersenn S
    Clin Endocrinol (Oxf); 2010 Aug; 73(2):153-60. PubMed ID: 20039892
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Supine or sitting? the voice of the patient stakeholders: economics vs clinically and medically sound.
    Sussman I; Rothwell T; Wilson A
    Clin Endocrinol (Oxf); 2015 Mar; 82(3):464-5. PubMed ID: 25265273
    [No Abstract]   [Full Text] [Related]  

  • 12. Single-centre study of the diagnostic performance of plasma metanephrines with seated sampling for the diagnosis of phaeochromocytoma/paraganglioma.
    Boot C; Toole B; Johnson SJ; Ball S; Neely D
    Ann Clin Biochem; 2017 Jan; 54(1):143-148. PubMed ID: 27170024
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Analysis of plasma 3-methoxytyramine, normetanephrine and metanephrine by ultraperformance liquid chromatography-tandem mass spectrometry: utility for diagnosis of dopamine-producing metastatic phaeochromocytoma.
    Peitzsch M; Prejbisz A; Kroiß M; Beuschlein F; Arlt W; Januszewicz A; Siegert G; Eisenhofer G
    Ann Clin Biochem; 2013 Mar; 50(Pt 2):147-55. PubMed ID: 23512172
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reference intervals for LC-MS/MS measurements of plasma free, urinary free and urinary acid-hydrolyzed deconjugated normetanephrine, metanephrine and methoxytyramine.
    Eisenhofer G; Peitzsch M; Kaden D; Langton K; Mangelis A; Pamporaki C; Masjkur J; Geroula A; Kurlbaum M; Deutschbein T; Beuschlein F; Prejbisz A; Bornstein SR; Lenders JWM
    Clin Chim Acta; 2019 Mar; 490():46-54. PubMed ID: 30571948
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Optimized procedures for testing plasma metanephrines in patients on hemodialysis.
    Pamporaki C; Prejbisz A; Małecki R; Pistrosch F; Peitzsch M; Bishoff S; Mueller P; Meyer I; Reimann D; Hanus K; Januszewicz A; Bornstein SR; Parmentier S; Kunath C; Lenders JWM; Eisenhofer G; Passauer J
    Sci Rep; 2021 Jul; 11(1):14706. PubMed ID: 34282182
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A high rate of modestly elevated plasma normetanephrine in a population referred for suspected PPGL when measured in a seated position.
    Boyd J; Leung AA; Sadrzadeh HS; Pamporaki C; Pacak K; Deutschbein T; Fliedner S; Kline GA
    Eur J Endocrinol; 2019 Sep; 181(3):301-309. PubMed ID: 31370003
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The diagnostic efficacy of urinary fractionated metanephrines measured by tandem mass spectrometry in detection of pheochromocytoma.
    Perry CG; Sawka AM; Singh R; Thabane L; Bajnarek J; Young WF
    Clin Endocrinol (Oxf); 2007 May; 66(5):703-8. PubMed ID: 17388796
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Overnight/first-morning urine free metanephrines and methoxytyramine for diagnosis of pheochromocytoma and paraganglioma: is this an option?
    Peitzsch M; Kaden D; Pamporaki C; Langton K; Constantinescu G; Conrad C; Fliedner S; Sinnott RO; Prejbisz A; Därr R; Lenders JWM; Bursztyn M; Eisenhofer G
    Eur J Endocrinol; 2020 May; 182(5):499-509. PubMed ID: 32187575
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Plasma-free vs deconjugated metanephrines for diagnosis of phaeochromocytoma.
    Pamporaki C; Därr R; Bursztyn M; Glöckner S; Bornstein SR; Lenders JW; Pacak K; Krinner A; Eisenhofer G
    Clin Endocrinol (Oxf); 2013 Oct; 79(4):476-83. PubMed ID: 23461656
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dietary influences on plasma and urinary metanephrines: implications for diagnosis of catecholamine-producing tumors.
    de Jong WH; Eisenhofer G; Post WJ; Muskiet FA; de Vries EG; Kema IP
    J Clin Endocrinol Metab; 2009 Aug; 94(8):2841-9. PubMed ID: 19567530
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.